Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Performance
Top News
More News
Tobira Therapeutics Completes Financing and Merger with Regado Biosciences
May 04, 2015
Newly NASDAQ-Listed TBRA Has Approximately $70 Million to Complete NASH Phase 2b Study and Build Multi-Indication Platform with Cenicriviroc
Read More
from
PR Newswire
Tobira Therapeutics Highlights Presentations at The International Liver Congress 2015
April 08, 2015
from
PR Newswire
More News
Read More
Tobira Therapeutics Highlights Presentations at the AASLD's Industry Colloquium for Novel Targets and Therapies in Liver Disease
March 20, 2015
from
PR Newswire
Tobira Therapeutics Closes Financing to Support Development of CVC in Non-Alcoholic Steatohepatitis
March 09, 2015
from
PR Newswire
Tobira Therapeutics Doses First Subject in Phase 1 Clinical Trial of Cenicriviroc and Pioglitazone
January 20, 2015
from
PR Newswire
REMINDER: Regado Biosciences and Tobira Therapeutics Merger Agreement Conference Call Set for 8:30 a.m. EST Today, Jan. 20
January 20, 2015
from
PR Newswire
Regado Biosciences and Tobira Therapeutics Announce Merger Agreement to Create Leading NASH Company
January 14, 2015
from
PR Newswire
Durable goods orders plunge, markets collapse
September 25, 2014
category
Market News
from
MarketMinute.com Market Updates
Regado Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update
November 05, 2014
from
PR Newswire
Regado Biosciences to Provide Third Quarter 2014 Financial Results
October 30, 2014
from
PR Newswire
Regado Biosciences Appoints Michael A. Metzger CEO
October 10, 2014
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates
Bots go here